Suda Takeshi, Suda Kieko, Liu Dexi
Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.
Mol Ther. 2008 Jun;16(6):1098-104. doi: 10.1038/mt.2008.66. Epub 2008 Apr 8.
The recently developed hydrodynamic delivery method makes it possible to deliver DNA and RNA into parenchyma cells by intravascular injection of nucleic acid-containing solution. While this procedure is effective in rodents, it is difficult to perform in large animals, because manual control while delivering the injection cannot be sufficiently reliable for achieving a just-right hydrodynamic pressure in targeted tissue. In order to overcome this problem, we have developed a computer-controlled injection device that uses real-time intravascular pressure as a regulator. Using the new injection device, and mouse liver as the model organ, we demonstrated continuous injection at a single pressure and different pressures, and also serial (repeated) injections at intervals of 250 ms, by programming the computer according to the need. When assessed by reporter plasmids, the computer-controlled injection device exhibits gene delivery efficiency similar to that of conventional hydrodynamic injection. The device is also effective in gene delivery to kidney and muscle cells in rats, with plasmids or adenoviral vectors as gene carriers. Successful gene delivery to liver and kidney was also demonstrated in pigs, with the computer-controlled injection being combined with image-guided catheterization. These results represent a significant advance in in vivo gene delivery research, with potential for use in gene therapy in humans.
最近开发的流体动力学递送方法使得通过血管内注射含核酸溶液将DNA和RNA递送至实质细胞成为可能。虽然该方法在啮齿动物中有效,但在大型动物中难以实施,因为在递送注射时手动控制对于在目标组织中实现恰到好处的流体动力学压力而言不够可靠。为了克服这一问题,我们开发了一种以实时血管内压力作为调节器的计算机控制注射装置。使用该新型注射装置,并以小鼠肝脏作为模型器官,我们通过根据需要对计算机进行编程,展示了在单一压力和不同压力下的连续注射,以及以250毫秒的间隔进行的系列(重复)注射。当通过报告质粒进行评估时,计算机控制注射装置表现出与传统流体动力学注射相似的基因递送效率。该装置在以质粒或腺病毒载体作为基因载体时,对大鼠的肾脏和肌肉细胞进行基因递送也有效。在猪中,通过将计算机控制注射与图像引导导管插入术相结合,也证明了向肝脏和肾脏成功进行了基因递送。这些结果代表了体内基因递送研究的重大进展,具有在人类基因治疗中应用的潜力。